Evidence map›Paper›PMID 39850168›Full record

ArticleCureus2024

Novel Syndrome With Congenital Thumb Aplasia, Epilepsy, Cognitive Impairment, and Myopathy: A Case Report.

Josef Finsterer, Awini Barwari

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Josef FinstererNeurology, Neurology and Neurophysiology Center, Vienna, AUT.
Awini BarwariNeurology, Neurology and Neurophysiology Center, Vienna, AUT.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The combination of thumb aplasia, epilepsy, cognitive impairment, skeletal deformities, and myopathy has not been previously reported. The patient is a 22-year-old man with congenital bilateral thumb aplasia, developmental delay, and cognitive impairment who suffered a first tonic-clonic seizure at the age of 16 and was treated with valproic acid (VPA). At the age of 22, lamotrigine was added due to seizure recurrences and absences. Neurological examination revealed cognitive impairment, latent strabismus, thumb aplasia, orthopedic anomalies of the feet, gnome calves, and absent tendon reflexes. Electromyography indicated a myopathy. Although the family history was negative for thumb aplasia, epilepsy, mental retardation, myopathy, and orthopedic disease, the clinical presentation of the index patient was suspected due to a sporadic genetic defect at either the chromosomal or gene level. Chromosomal micro- or macrodeletions or duplications as well as point mutations in PTPRQ, SALL4, RECQL4, and SALL1 have previously been identified in syndromic thumb aplasia. In conclusion, the presented case represents a novel syndrome with the phenotypic manifestations of epilepsy, myopathy, cognitive impairment, mild dysmorphism, and congenital thumb aplasia. Physicians should remain vigilant and interested in patients with syndromic thumb aplasia.

Indexed as

chromosomal defectcognitive declinedevelopmental delayepilepsythumb aplasia

Identifiers

PMID39850168
PMCPMC11756846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.